Is This the Best Biotech Investment in America? | 03.08

Post a Comment
His prediction doesn't seem so unlikely anymore. 

3 Aug, 2022 Unsubscribe


Editor's Note: Occasionally, an opportunity comes to our attention at The Market Holders we believe readers like you will find valuable. The message below from one of our partners is one we believe you should take a close look at.


Hello Fellow Investor!

Back in December, an ex-Wall Street CEO made a bold prediction about the biotech sector…

He stated that "M & A activity will start accelerating soon."

It seemed unlikely at the time…

But the next day, Pfizer bought Arena Pharmaceuticals…and shares jumped up 83% in a single day.

Then, just 9 days later, Novartis bought Gyroscope Therapeutics in a $1.6 billion deal.

His prediction doesn't seem so unlikely anymore.

Click here to find out which biotech firm I predict will get taken over next…and how it could unlock huge profits for forward-thinking investors.

"The Buck Stops Here"
Dylan Jovine
CEO and Founder
Behind the Markets

The Market Holders

You received this email as a result of your consent to receive 3rd party offers at our another website.

This ad is sent on behalf of Behind The Markets, 4181 NW 1st Ave #8, Boca Raton, FL 33431. If you would like to unsubscribe from receiving offers from Behind The Markets please click here.

To ensure you receive our emails to your inbox, be sure to whitelist us.


© 2022 The Market Holders. All Rights Reserved.

1201 Wilson Blvd #27
United States of America

Privacy Policy | Terms & Conditions | Unsubscribe 

Related Posts

There is no other posts in this category.

Post a Comment

Subscribe Our Newsletter